Spinal Cord Stimulator denials in California external review

In the California DMHC record, independent physician reviewers decided 21 published external-review cases involving Spinal Cord Stimulatorand overturned the plan’s denial in 38.1%. That is a historical result among cases that reached this program, not a forecast for an individual appeal.

California DMHC decisions
21
2005–2024
Overturned
38.1%
8 denials reversed

Conditions behind Spinal Cord Stimulator denials

What insurers denied — and how those fights ended.
CategoryDecisionsOverturned
Complex Regional Pain Syndrome3
33.3%

What the insurer actually argued

Denials fall into different categories, and they don’t succeed equally — so the reason on your letter changes how you should answer it.
Reason givenDecisionsOverturned
Medical Necessity
The plan said the care wasn’t medically necessary. The most common fight, and the most winnable.
16
37.5%
Experimental/Investigational
The plan called the treatment unproven. These turn on published evidence, so the appeal is a literature argument.
5
40%
Typical time to a decision
21 days
Most land between 8 and 21 days
Handled as urgent
23.8%
Expedited when a delay would cause harm

What the reviewers wrote

Excerpts from the independent reviewers’ published findings — the actual reasoning, quoted, not summarised.

Where the denial was overturned

Findings: The physician reviewer found that Nature of Statutory Criteria/Case Summary: The patient requested authorization and coverage for a spinal cord stimulator.A review of current medical literature reveals that there is strong evidence supporting the use of spinal cord stimulation (SCS) for treating chronic refractory back pain with and without radicular features producing clinically relevant outcomes. A study reviewing the efficacy of SCS concluded that “the option of spinal cord stimulation should be considered after conservative therapy has failed”. The authors cited large-scale randomized controlled clinical studies that showed that high-frequency forms of SCS were effective for the treatment of patients with chronic back pain. Further, the authors of another study evaluated the benefits of high-frequency SCS for surgery in patients suffering from back pain.
Medical Necessity · 2024 · IMR MN24-42399
Nature of Statutory Criteria/Case Summary: The patient has requested authorization and coverage for a spinal cord stimulator. Amirdelfan and colleagues reported on a prospective, multicenter, randomized controlled trial evaluating the long-term quality of life improvement for patients with chronic intractable back and leg pain with the use of spinal cord stimulation. The authors found that of the 171 patients who received a permanent spinal cord stimulation device implant, a higher proportion of patients had marked improvement in their level of disability with moderate to minimal impact on their daily function versus the control group at one-year follow-up.
Medical Necessity · 2022 · IMR MN22-36953

Where the denial was upheld

Worth reading too — these show what an appeal has to overcome.
The patient has requested authorization and coverage for a spinal cord stimulator. Researchers evaluated the benefits of high frequency spinal cord stimulation for surgery naïve patients with low back pain. The authors reported that their results showed a 50% improvement of low back pain with a mean follow-up of 306 days after implantation. They also concluded that, the option of spinal cord stimulation should be considered after conservative therapy has failed. In this case, the patient has diffuse low back pain with radiation into the right anterolateral thigh and right groin along with a history of multiple falls. The patient’s chronic pain involves the neck, shoulders, fingers, calves and feet. She has magnetic resonance imaging (MRI) results confirming degenerative changes at L3-4 and L4-5 with foraminal narrowing.
Medical Necessity · 2019 · IMR MN19-32309
Nature of Statutory Criteria/Case Summary: An enrollee has requested authorization and coverage for spinal cord stimulator (CPT 62350) for treatment of her transverse myelitis. Findings: Two physician reviewers found that the requested procedure is not likely to be more beneficial for treatment of the patient’s medical condition than any available standard therapy. The patient presents with chronic back pain and lower extremity symptoms. She had an acute neurologic event years ago with residual symptoms. There is no documentation the patient has tried physical therapy, transcutaneous electrical nerve stimulation (TENS), injections, behavioral therapy, or a back brace in the last 24 months. In addition, there is no documentation of an electromyogram (EMG) to rule out peripheral neuropathy for her burning pain.
Experimental/Investigational · 2017 · IMR EI17-25421

Figures and quotations on this page come from 42,749 published decisions in the California DMHC Independent Medical Review dataset. These are California external-review outcomes. Other state and federal programs have different eligibility rules, processes, and current availability; the rates here do not transfer to those programs or predict an individual result. Excerpts are quoted verbatim from the public record and describe this treatment generally, not any individual case.

How to use this in your appeal

These outcomes describe eligible cases completed through California DMHC’s Independent Medical Review program. They do not estimate the chance that an internal appeal, an external review in another jurisdiction, or your individual case will succeed. Use the record to identify evidence patterns involving Spinal Cord Stimulator, then check the rights and deadlines that apply to your plan.

SOURCE: CALIFORNIA DMHC INDEPENDENT MEDICAL REVIEW OUTCOMES (CHHS OPEN DATA) · AGGREGATES + DEIDENTIFIED DECISION EXCERPTS/REFERENCE IDS · METHODOLOGY

Not legal or medical advice. Coverage Rights is a self-help tool that helps you prepare your own appeal. For advice about your specific situation, talk to a licensed attorney or your doctor.

Denied Spinal Cord Stimulator? Use the California record to prepare.

Explain my denial — freeStart my appeal · $39